TY - JOUR
T1 - Endoscopic third ventriculostomy for adults with hydrocephalus
T2 - Creating a prognostic model for success: Protocol for a retrospective multicentre study (Nordic ETV)
AU - Tefre, Sondre
AU - Lilja-Cyron, Alexander
AU - Arvidsson, Lisa
AU - Bartek, Jiri
AU - Corell, Alba
AU - Forsse, Axel
AU - Glud, Andreas Nørgaard
AU - Hamdeh, Sami Abu
AU - Hansen, Frederik Lundgaard
AU - Huotarinen, Antti
AU - Johansson, Conny
AU - Kämäräinen, Olli Pekka
AU - Korhonen, Tommi
AU - Kotkansalo, Anna
AU - Mansoor, Nadia Mauland
AU - Mireles, Eduardo Erasmo Mendoza
AU - Miscov, Rares
AU - Munthe, Sune
AU - Nittby-Redebrandt, Henrietta
AU - Obad, Nina
AU - Pedersen, Lars Kjelsberg
AU - Posti, Jussi
AU - Raj, Rahul
AU - Satopää, Jarno
AU - Stahl, Nils
AU - Tetri, Sami
AU - Tobieson, Lovisa
AU - Juhler, Marianne
N1 - Publisher Copyright:
©
PY - 2022
Y1 - 2022
N2 - Introduction Endoscopic third ventriculostomy (ETV) is becoming an increasingly widespread treatment for hydrocephalus, but research is primarily based on paediatric populations. In 2009, Kulkarni et al created the ETV Success score to predict the outcome of ETV in children. The purpose of this study is to create a prognostic model to predict the success of ETV for adult patients with hydrocephalus. The ability to predict who will benefit from an ETV will allow better primary patient selection both for ETV and shunting. This would reduce additional second procedures due to primary treatment failure. A success score specific for adults could also be used as a communication tool to provide better information and guidance to patients. Methods and analysis The study will adhere to the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis reporting guidelines and conducted as a retrospective chart review of all patients≥18 years of age treated with ETV at the participating centres between 1 January 2010 and 31 December 2018. Data collection is conducted locally in a standardised database. Univariate analysis will be used to identify several strong predictors to be included in a multivariate logistic regression model. The model will be validated using K-fold cross validation. Discrimination will be assessed using area under the receiver operating characteristic curve (AUROC) and calibration with calibration belt plots. Ethics and dissemination The study is approved by appropriate ethics or patient safety boards in all participating countries. Trial registration number NCT04773938; Pre-results.
AB - Introduction Endoscopic third ventriculostomy (ETV) is becoming an increasingly widespread treatment for hydrocephalus, but research is primarily based on paediatric populations. In 2009, Kulkarni et al created the ETV Success score to predict the outcome of ETV in children. The purpose of this study is to create a prognostic model to predict the success of ETV for adult patients with hydrocephalus. The ability to predict who will benefit from an ETV will allow better primary patient selection both for ETV and shunting. This would reduce additional second procedures due to primary treatment failure. A success score specific for adults could also be used as a communication tool to provide better information and guidance to patients. Methods and analysis The study will adhere to the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis reporting guidelines and conducted as a retrospective chart review of all patients≥18 years of age treated with ETV at the participating centres between 1 January 2010 and 31 December 2018. Data collection is conducted locally in a standardised database. Univariate analysis will be used to identify several strong predictors to be included in a multivariate logistic regression model. The model will be validated using K-fold cross validation. Discrimination will be assessed using area under the receiver operating characteristic curve (AUROC) and calibration with calibration belt plots. Ethics and dissemination The study is approved by appropriate ethics or patient safety boards in all participating countries. Trial registration number NCT04773938; Pre-results.
KW - Epidemiology
KW - Neuropathology
KW - Neuroradiology
KW - Neurosurgery
U2 - 10.1136/bmjopen-2021-055570
DO - 10.1136/bmjopen-2021-055570
M3 - Journal article
C2 - 35105647
AN - SCOPUS:85123974529
VL - 12
JO - BMJ Open
JF - BMJ Open
SN - 2044-6055
IS - 1
M1 - e055570
ER -